ALK-Abello A/S operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Christian Hansen Holding with three other
pharmaceutical manufacturers in Europe:
sales of 22.81 million Euros [US$26.77 million]
of which 96%
was Product Sales),
Horizon Discovery Group PLC
of UNITED KINGDOM
(£58.25 million [US$76.05 million]
of which 57%
was Research Reagents), and
Bavarian Nordic AS
(662.49 million Danish Kroner [US$104.43 million]
of which 100%
Christian Hansen Holding reported sales of 3.27 billion Danish Kroner (US$516.08 million)
December of 2019.
increase of 12.3%
versus 2018, when the company's sales were 2.92 billion Danish Kroner.
Sales of Slit - Tablets saw an increase
that was more than double the company's growth rate: sales were up
45.0% in 2019, from
671.00 million Danish Kroner to 973.00 million Danish Kroner.